BLFS
Biolife Solutions
$34.92
−$0.01 (−0.03%)Sep 10, 2026
Key metrics
The numbers that frame BLFS today
- Market cap
- $1.71B
- P/E (TTM)
- 29.5
- EV / FCF
- 222.7
- Gross margin
- 63.9%
- EV / Sales
- 16.5
- ROIC
- 7.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $17.86
- 52wk High
- $38.10
Growth
Revenue and earnings trend for BLFS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BLFS
Is Biolife Solutions a good buy?
Hold. Biolife Solutions has excellent momentum, but poor quality makes the setup mixed. Growth looks strong, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Biolife Solutions is selling at a high price.
What is the market capitalization of BLFS?
Biolife Solutions's market capitalization is $1.71B.
What is the P/E ratio for BLFS stock?
Biolife Solutions's current P/E ratio is 29.5.
What is the 52-week high for BLFS stock?
The 52-week high for Biolife Solutions is $38.10. The current close of $34.92 is 8.3% below that high.
What is the 52-week low for BLFS stock?
The 52-week low for Biolife Solutions is $17.86. The current close of $34.92 is 95.5% above that low.
Does BLFS stock pay dividends?
Biolife Solutions does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BLFS?
Biolife Solutions's Debt / Equity ratio is 0.04.